首页 | 本学科首页   官方微博 | 高级检索  
检索        

乌司他丁对心内直视手术患者红细胞脂质过氧化的影响
引用本文:沈金美,李李,何小京,姚茂金,常业恬.乌司他丁对心内直视手术患者红细胞脂质过氧化的影响[J].中南大学学报(医学版),2004,29(2):187-189.
作者姓名:沈金美  李李  何小京  姚茂金  常业恬
作者单位:中南大学湘雅二医院,麻醉科,长沙,410011;中南大学湘雅二医院,中心实验室,长沙,410011
摘    要:目的:观察乌司他丁对心内直视手术患者红细胞脂质过氧化损伤的保护作用。方法:选择20例首次择期行心脏瓣膜置换术患者,随机分为对照组(C组)和乌司他丁组(W组),每组各10例。分别于诱导后切皮前(T1)、转流后30 min(T2)、停体外循环时(T3)、主动脉开放后30 min(T4)、术毕24 h(T5)抽取动脉血,测定血浆丙二醛(P-MDA)含量,每个红细胞丙二醛(E-MDA)含量,红细胞超氧化物歧化酶(E-SOD)活性。结果:C组体外循环开始,P-MDA,E-MDA即开始升高,至术毕24 h仍未恢复至术前水平(P<0.001);W组P-MAD,E-MDA含量在主动脉开放30 min(T4)时,较术前明显增高(P<0.001),至术毕24 h已基本恢复至术前水平。两组E-SOD活性在转流30 min时高于术前水平,C组其他时点均低于术前水平(P<0.001),W组仅在T4时低于术前水平;但C组相应时点P-MDA,E-MDA均高于同时点W组,E-SOD活性明显低于W组(P<0.05)。结论:体外循环期间使用乌司他丁能减轻红细胞脂质过氧化损伤。

关 键 词:胰蛋白酶抑制剂  心肺转流术  红细胞  脂质过氧化  乌司他丁
文章编号:1672-7347(2004)02-0187-03
收稿时间:2003-05-29
修稿时间:2003年5月29日

Effects of ulinastatin on erythrocyte  lipid peroxidation in patients undergoing open heart surgery
SHEN Jin mei,LI Li ,HE Xiao jing,et al..Effects of ulinastatin on erythrocyte  lipid peroxidation in patients undergoing open heart surgery[J].Journal of Central South University (Medical Sciences)Journal of Central South University (Medical Sciences),2004,29(2):187-189.
Authors:SHEN Jin mei  LI Li  HE Xiao jing  
Institution:Department of Anesthesiology,Second Xiangya Hospital,  Central South University,  Changsha  410011, China
Abstract:OBJECTIVE: To investigate the effects of ulinastatin on erythrocyte lipid peroxidation in patients undergoing open heart surgery. METHODS: Twenty adult patients with rheumatic heart disease undergoing elective value replacement were divided randomly into 2 groups of 10 patients each: a control group (group C) and an ulinastatin group (group W). The patients were premedicated with intramuscular morphine 0.08 mg/kg and scopolamine 0.06 mg/kg. Anesthesia was induced with midazolam 0.1 mg/kg, fentanyl 5 microg/kg and vecuronium 0.1 mg/kg. After the tracheal intubation, the patients were mechanically ventilated. Anesthesia was maintained with midazolam, fentanyl and isoflurane. Blood samples were taken from radial artery before the operation (T1), 30 min after the initiation of CPB (T2), at the end of the CPB (T3), 30 min after the aorta declamping (T4) and 24 h after the operation (T5) for the determination of plasma and erythrocyte MDA (P-MDA and E-MDA) and erythrocyte SOD (E-SOD). RESULTS: The levels of P-MDA and E-MDA increased significantly after the initiation of CPB and the level of E-SOD was higher than the baseline level at T2, and then decreased from T3 to T5 in group C (P <0.001). The levels of P-MDA and E-MDA didn't increased until T4 (P <0.001) and returned to the baseline level at T5 in group W. The levels of P-MDA and E-MDA were significantly higher in group C than those in group W and the level of E-SOD was markedly lower than that in group W (P <0.05). CONCLUSION: Ulinastatin can alleviate erythrocyte lipid peroxidation in patients undergoing open heart surgery.
Keywords:trypsin inhibitors  cardiopulmonary bypass  erythrocyte  lipid peroxidation  ulinastatin
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中南大学学报(医学版)》浏览原始摘要信息
点击此处可从《中南大学学报(医学版)》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号